ResearcherZhejiang UniversityActive in the last 2 years
Weijia Fang
Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.
Their work
- Papers
- 0
- Trials
- 7 (principal investigator on 7)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 1
2015: 2 trials · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 trial · 2021: 1 trial · 2022: none · 2023: 2 trials · 2024: 1 trial
Trials 7
- Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors Principal investigator NCT07010523↗
- UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors Principal investigator NCT05848999↗
- A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors Principal investigator NCT06043466↗
- IMC001 for Clinical Research on Advanced Digestive System Malignancies Principal investigator NCT05028933↗
- CART Therapy in GUCY2C-positive Digestive Tract Tumors Principal investigator NCT04652219↗
- S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer Principal investigator NCT02131493↗
- Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer Principal investigator NCT02558868↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ying Yuan · 1 shared trial, 2023 · strength 0.58
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.